111in-dac

**111In-DAC** is a radiopharmaceutical imaging agent labeled with the radioisotope Indium-111. It is designed for use as a diagnostic tool in nuclear medicine, specifically for planar and SPECT imaging to detect lung cancer and brain cancer consistent with metastatic lung cancer. The agent works by binding to target tissues, allowing visualization via gamma camera due to the emission of gamma rays from Indium-111 decay. Its mechanism relies on the radiolabeling properties of Indium-111, which enables sensitive detection of tumors or metastases during imaging procedures[9][4][2]. The developer associated with clinical studies is Copharos.

Brand names

111in-dac

Other names

indium in-111 dacindium in 111 dacIn-DAC